Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

nintedanib

ABPI appoints Mike Thompson as chief executive

He replaces acting chief executive officer Alison Clough

- PMLiVE

UK HCPs back transparency over their pharma payments

Survey comes as pharma companies prepare for payment disclosure database

ABPI’s Stephen Whitehead steps down

Leaves the UK pharma trade body after four years as its CEO

- PMLiVE

Boehringer hails its ‘landmark year’ in respiratory

Marketing and sales head Allan Hillgrove on the company's recent efforts

- PMLiVE

FDA clears Jardiance combo for type 2 diabetes

Combination treatment Synjardy is fifth drug to come from Boehringer/Lilly diabetes alliance

Eli Lilly HQ

Lilly and Boehringer launch Lantus biosimilar in UK

Competition in the insulin drug market begins to heat up

ABPI London offices

Government crackdown on doctor-pharma payments

Physicians could face jail over accepting some industry gifts under new plans

- PMLiVE

Jardiance is first diabetes drug to improve CV outcomes

Lilly/Boehringer drug could gain market share boost from new data

- PMLiVE

Boehringer COPD drug ‘could give patients more independence’

New data shows Stiolto improves patients’ lives

Boehringer Ingelheim headquarters

Boehringer returns to growth in first half

German firm back on track after a tough sales period

ABPI Scotland appoints Sandra Auld as director

Takes over from Andrew-Powrie Smith who left to join EPFIA this year

Boehringer Ingelheim headquarters

Hikma pays $2.6bn for Boehringer’s US generics unit

Follows Teva’s $40.5bn purchase of Allgeran’s generics business earlier this week

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links